Table 3 Evaluation of candidiasis and mucositis in the groups studied
Variables | Group | |||
|---|---|---|---|---|
GHipo (n = 23) | Gconv (n = 43) | Total (n = 66) | p-value | |
Candidiasis (Intermediate evaluation) | n (%) | n (%) | n (%) | |
No | 22 (95.7%) | 38 (88.4%) | 60 (90.9%) | 0.656# |
Yes | 1 (4.3%) | 5 (11.6%) | 6 (9.1%) | |
Candidiasis (Final evaluation) | ||||
No | 19 (82.6%) | 37 (86.0%) | 56 (84.8%) | 0.730# # |
Yes | 4 (17.4%) | 6 (14%) | 10 (15.2%) | |
Mucositis (Intermediate evaluation) | n (%) | n (%) | n (%) | |
No | 9 (39.1%) | 25 (58.1%) | 34 (51.5%) | 0.141# # |
Yes | 14 (60.9%) | 18 (41.9%) | 32 (48.5%) | |
Grade of mucositis (Intermediate evaluation) Non-detectable (grade 0) | 9 (39,1%) | 25 (58,1%) | 34 (51,5%) | |
1 and 2 | 10 (43,5%) | 18 (41,8%) | 28 (42,4%%) | < 0.05# |
3 and 4 | 4 (17,4%) | 0 (0%) | 4 (6,1%) | |
Grade of mucositis (Final evaluation) Non-detectable (grade 0) | 6 (26,1%) | 27 (62,8%) | 33 (50,0%) | |
1 and 2 | 11 (47,8%) | 15 (34,9%) | 26 (39,4%) | < 0.05# |
3 and 4 | 6 (26,1%) | 1 (2.3%) | 7 (10,6%) | |